The stock of Amazon.com, Inc. (NASDAQ:AMZN) is a huge mover today! The stock increased 0.80% or $9.34 during the last trading session, reaching $1173.47. About 808,967 shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 37.41% since December 14, 2016 and is uptrending. It has outperformed by 20.71% the S&P500.The move comes after 8 months positive chart setup for the $565.46 billion company. It was reported on Dec, 14 by Barchart.com. We have $1220.41 PT which if reached, will make NASDAQ:AMZN worth $22.62B more.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $77.22 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 32.74 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Among 50 analysts covering Amazon.com (NASDAQ:AMZN), 47 have Buy rating, 0 Sell and 3 Hold. Therefore 94% are positive. Amazon.com had 238 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Pacific Crest on Friday, July 29. Cantor Fitzgerald maintained Amazon.com, Inc. (NASDAQ:AMZN) on Friday, June 16 with “Buy” rating. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Outperform” rating by BMO Capital Markets on Wednesday, March 2. Maxim Group maintained the stock with “Buy” rating in Thursday, July 20 report. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Outperform” rating given on Friday, June 10 by William Blair. The firm earned “Buy” rating on Wednesday, July 12 by Piper Jaffray. The company was maintained on Friday, July 24 by Citigroup. UBS maintained the stock with “Buy” rating in Friday, October 23 report. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Outperform” rating by Macquarie Research on Tuesday, December 22. The firm has “Buy” rating by Citigroup given on Friday, July 29.
Investors sentiment decreased to 1.26 in Q2 2017. Its down 0.10, from 1.36 in 2017Q1. It dropped, as 64 investors sold Amazon.com, Inc. shares while 542 reduced holdings. 153 funds opened positions while 670 raised stakes. 285.20 million shares or 2.71% less from 293.14 million shares in 2017Q1 were reported. Lmm Limited Liability Corporation invested 4.77% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). 9,776 were reported by Advisory Serv Ntwk Lc. Kemnay Advisory Svcs Incorporated holds 7.89% or 14,078 shares. Ashford Mgmt owns 1,516 shares. Susquehanna Grp Ltd Liability Partnership reported 0.51% in Amazon.com, Inc. (NASDAQ:AMZN). Carnegie Cap Asset Mngmt Ltd Liability Com holds 0.79% or 6,517 shares in its portfolio. Blume Cap Inc reported 613 shares or 0.34% of all its holdings. Congress Asset Ma holds 57,486 shares. Tiemann Investment Advsr Limited Liability Company reported 0.9% stake. 3,364 are held by Gamble Jones Counsel. Davidson And Garrard holds 1.3% or 5,656 shares in its portfolio. Fairfield Bush invested in 11,625 shares or 3.61% of the stock. Holland Cap Limited Liability Company holds 4.76% or 112,380 shares. Century owns 1.60M shares. Smith Chas P And Assocs Pa Cpas stated it has 0.04% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN).
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions in North America and internationally. The company has market cap of $565.46 billion. It operates through the North America, International, and Amazon Web Services divisions. It has a 299.2 P/E ratio. The firm sells merchandise and content purchased for resale from vendors, as well as those offered by third-party sellers through retail Websites, such as amazon.com, amazon.ca, amazon.com.mx, amazon.com.au, amazon.com.br, amazon.cn, amazon.fr, amazon.de, amazon.in, amazon.it, amazon.co.jp, amazon.nl, amazon.es, and amazon.co.uk.
Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on February, 1. They expect $1.96 EPS, up 27.27% or $0.42 from last year’s $1.54 per share. AMZN’s profit will be $944.47 million for 149.68 P/E if the $1.96 EPS becomes a reality. After $0.52 actual EPS reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts 276.92% EPS growth.
Since August 3, 2017, it had 0 buys, and 8 insider sales for $13.22 million activity. Reynolds Shelley sold $536,666 worth of stock or 544 shares. Another trade for 2,334 shares valued at $2.31 million was sold by Olsavsky Brian T. $697,038 worth of Amazon.com, Inc. (NASDAQ:AMZN) was sold by WILKE JEFFREY A on Tuesday, August 15. Shares for $2.05 million were sold by Blackburn Jeffrey M. 1,985 shares were sold by Jassy Andrew R, worth $1.96 million. 2,334 shares valued at $2.30 million were sold by Zapolsky David on Tuesday, August 15.
Cryder Capital Partners Llp holds 12.37% of its portfolio in Thermo Fisher Scientific Inc. for 193,360 shares. Veritas Investment Management Llp owns 411,854 shares or 10.5% of their US portfolio. Moreover, Caledonia Investments Plc has 8.35% invested in the company for 168,917 shares. The California-based Grand Jean Capital Management Inc has invested 7.4% in the stock. Veritas Investment Management (Uk) Ltd, a United Kingdom-based fund reported 109,425 shares.
Since January 1, 0001, it had 0 buys, and 6 sales for $9.13 million activity.
Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $2.67 EPS, up 10.79% or $0.26 from last year’s $2.41 per share. TMO’s profit will be $1.07 billion for 18.03 P/E if the $2.67 EPS becomes a reality. After $2.31 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 15.58% EPS growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.